This is a federal delivery order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The order is placed against Qiagen's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract #75F40121D00009. The contract has a ceiling value of $93,146.18 and a period of performance through June 14, 2025. Qiagen, as a prime contractor, has provided similar products and services to a variety of federal agencies, including the Departments of Health and Human Services, Veterans Affairs, Defense, and Justice. This order does not utilize any set-aside designations.
Generated 8/7/24, 9:41 AM